Search results for "Urinary tract infections"
Warning on an antipsychotic; generic rosuvastatin approval
This update covers new warnings on the entire class of opioids and approval of the first leadless pacemaker approved to treat heart rhythm disorders.
https://immattersacp.org/archives/2016/06/fda.htm
1 Jun 2016
Updated warning issued on risks of fluoroquinolones
Fluoroquinolone use for sinusitis, bronchitis, and uncomplicated urinary tract infections should be reserved for patients who do not have alternative treatment options, according to an FDA safety communication.
https://immattersacp.org/weekly/archives/2016/05/24/5.htm
24 May 2016
Warning on diabetes drugs, approval of adjuvant flu vaccine
This update covers a warning on sodium-glucose cotransporter-2 inhibitors and approval of a trivalent vaccine for the prevention of seasonal influenza in people age 65 years and older.
https://immattersacp.org/archives/2016/02/fda.htm
1 Feb 2016
Internists interacting with retail clinics
Primary care physicians are seeing more patients after they've already been to a retail health clinic. Experts say that a more patient-centered model needs to evolve to combat the ease of seeking care outside the doctor's office.
https://immattersacp.org/archives/2016/02/retail-clinics.htm
1 Feb 2016
Latest diabetes drugs have a learning curve
The onus is on internists to understand the newer classes of incretins such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and dipeptidyl peptidase-4 (DPP-4) inhibitors. They hold promise for better treatments, but they are new and not as well understood as older treatments.
https://immattersacp.org/archives/2015/10/diabetes.htm
1 Oct 2015
Know your kidney stones
Knowing what makes up a patient's kidney stones determines how an internist might treat the problem. But, one expert cautions, while 1 type of kidney stone is far more prevalent, there are 4 other kinds, and they may require subspecialty treatment.
https://immattersacp.org/archives/2015/07/kidney-stones.htm
1 Jul 2015
Warnings on testosterone, new antibiotic approved
This update covers a label change on testosterone products clarifying that they are approved only for men who have low testosterone levels, as well as the approval of ceftazidime-avibactam (Avycaz) to treat complicated intra-abdominal infections.
https://immattersacp.org/archives/2015/05/fda.htm
1 May 2015
New heart disease test, drugs for flu, weight management
This update covers a new test to predict risk of future coronary heart disease events, the first neuraminidase inhibitor for influenza, and a new GLP-1 agonist for obese people.
https://immattersacp.org/archives/2015/03/fda.htm
1 Mar 2015
Urinary incontinence is overlooked but treatable
This issue covers topics including urinary incontinence, the new drug class of SGLT2 inhibitors for diabetes, and more on the principles of diabetes care.
https://immattersacp.org/archives/2015/02/editors.htm
1 Feb 2015
SGLT2 inhibitors change glucose dynamic
The kidney's role in glucose production is as a producer and consumer of it, as well as filtering and reabsorbing it. SGLT2 inhibitors change that dynamic, creating new mechanisms, benefits and risks, and uncertainties that internists should know about this new drug class.
https://immattersacp.org/archives/2015/02/sglt2.htm
1 Feb 2015